Pyquvi Suspension
Product Images NDC 73289-0089

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pyquvi (NDC 73289-0089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aucta Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-2-1 (Carton Label 02 1)

Packaging label for PYQUI oral suspension, containing deflazacort at 22.75 mg/mL strength. The label indicates a 13 mL bottle size and states the product is for oral administration only. Manufactured by Aucta Pharmaceuticals, Inc., Piscataway, NJ. The label includes storage instructions, contents of the carton, and features the Aucta Pharmaceuticals logo.*

FDA Label Image

Bottle-label-3 (Container Label 03)

Label for Pyquvi (deflazacort) Oral Suspension, 22.75 mg/mL, in a 13 mL bottle. The label states it is for oral administration only, manufactured by Aucta Pharmaceuticals, Inc., Piscataway, NJ. It includes storage instructions and a barcode.*

FDA Label Image

Figure E (Emflaza 06)

An instructional diagram of an oral dosing syringe labeled with parts "Plunger" and "Barrel." The syringe features measurement markings on the barrel for dose accuracy, used to administer liquid medication such as suspension.*

FDA Label Image

Figure F (Emflaza 07)

An instructional illustration showing a hand holding a syringe-like dropper with a plunger, being inserted into the neck of a bottle. The image includes a large downward arrow indicating the direction to insert or push the plunger into the bottle.*

FDA Label Image

Figure G (Emflaza 08)

An instructional illustration showing how to measure a dose of oral suspension using a syringe. The image highlights measuring the dose from the widest part of the plunger, with a zoomed-in view for clarity.*

FDA Label Image

Figure H (Emflaza 09)

An instructional illustration showing a hand holding a syringe-style measuring device with graduated markings, being inserted and rotated to remove a cap from a bottle. The image demonstrates how to open the bottle by twisting and lifting the measuring device.*

FDA Label Image

Figure I (Emflaza 10)

Illustration showing a hand holding a dropper above a small cup with liquid, with a downward arrow indicating the dropper is being inserted into the liquid. A spoon is placed beside the cup. This likely demonstrates a step in administering oral suspension medication.*

FDA Label Image

Figure J (Emflaza 11)

An instructional line drawing showing a hand stirring a spoon inside a cup filled with liquid. The arrow indicates the stirring motion, demonstrating how to mix a suspension properly before use.*

FDA Label Image

Figure K (Emflaza 12)

Instructional illustration showing a hand gripping a bottle cap and lifting it upward to open the bottle. The bottle appears to be a container for oral suspension medication.*

FDA Label Image

Figure L (Emflaza 13)

An instructional illustration showing a hand holding a syringe by the barrel with the thumb and forefinger, and the plunger being pulled upward as indicated by an upward arrow. It appears to demonstrate the correct technique for drawing liquid into the syringe.*

FDA Label Image

Figurea-b-jpg (Figurea)

An instructional illustration showing a hand holding a bottle with motion lines around the top and bottom, indicating the bottle should be shaken well before use.*

FDA Label Image

Figure-c (Figurec)

An instructional illustration showing a hand removing the cap from a bottle, with arrows indicating the direction of cap removal. The bottle is likely related to oral suspension medication.*

FDA Label Image

Figure-d (Figured Small)

An instructional illustration showing hands pressing down on a bottle adapter using both thumbs. It highlights the ribbed end of the adapter, demonstrating how to properly secure the adapter to the bottle.*

FDA Label Image

Figurea-1-tm (Pyquvi 1 Tm 1)

Illustration showing components of PYQUVI oral suspension including the oral suspension bottle, a household cup and spoon, bottle adapter, oral dispenser, and the oral suspension carton. The diagram labels each item to indicate what is included in the packaging for administering the medication.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of deflazacort, the active ingredient in PYQUVI oral suspension 22.75 mg/mL by Aucta Pharmaceuticals, Inc. The diagram shows the molecular skeleton with functional groups and bonds clearly identified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.